Patent Assignment
Reel/Frame 013869/0668
Assignment of Assignor's Interest
Recorded: 2003-03-19
Received: 2003-03-25
Pages: 3
Assignor
SUNTORY LIMITED
Executed: 2003-03-05
Assignee
DAIICHI SUNTORY PHARMA CO., LTD.
7-2, KOJIMACHI 5-CHOME, CHIYODA-KU, TOKYO, JPX, JAPAN
Covered Properties
(13)
Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same
Application:
10/331,508 →
A Pharmaceutical Component Based on Human Parathyroid Hormone and a Pharmaceutical Composition for Intranasal Administration Comprising the Component
Application:
10/312,726 →
NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient
Application:
10/243,737 →
Arylpiperidinol and Arylpiperidine Derivatives and Pharmaceuticals Containing the Same
Application:
10/196,362 →
Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same
Application:
10/118,045 →
Megakaryocyte differentiation factor
Application:
10/091,442 →
A Chymase Inhibitor for the Treatment of Eosinophilia
Application:
09/959,358 →
A Method of Treating Dermatitis Comprising Administering a Chymase Inhibitor
Application:
09/959,252 →
Preventive or Therapeutic Drugs for Fibrosis Containing Chymase Inhibitors as the Active Ingredient
Application:
09/959,232 →
1-Aryl-1,8-Naphthylidin-4-One Derivative as Type Iv Phosphodiesterase Inhibitor
Application:
09/907,741 →
Blood Vessel Lipid Deposition-Preventive Agent Comprising Chymase-Inhibitor
Application:
09/869,360 →
Methods of Using Phenylmethybenzoquinone and Hydroquinone Compounds for Treatment of Myocarditis, Dilated Cardiomyopathy and Heart Failure
Application:
09/856,072 →
Quinazoline Derivatives and Pharmaceutical Applications Therof
Application:
09/763,213 →